Literature DB >> 195006

The uncoupled relationship between the temperature-sensitivity and neurovirulence in mice of mutants of vesicular stomatitis virus.

S G Rabinowitz, T C Johnson, M C Dal Canto.   

Abstract

Inoculation of wild-type (wt) VSV intracerebrally (i.c.) in Swiss weanling mice results in a rapidly fatal illness with death in two to three days. In contrast, i.c. inoculation of temperature-sensitive (ts) VSV mutants G3I and G22, but not ts GII or ts G4I, results in a more slowly progressive central nervous system (CNS) disease with distinct neurological signs. Studies undertaken to evaluate the neurovirulence of ts VSV mutants indicated that the ability of ts mutants to produce pathological changes in the CNS of mice appeared related to their ability to replicate to high titre in brain and spinal cord. However, replication of ts VSV mutants in brain alone was not sufficient to produce clinical illness. More importantly, the ability of ts VSV mutants to replicate at non-permissive temperatures in vitro did not appear to correlate with neurovirulence. VSV harvests from brains and spinal cords of mice infected with each of the ts mutants were temperature-insensitive. In spite of their temperature-insensitivity, the biological behaviour of viruses recovered from CNS tissues was, surprisingly, not that which was characteristic of revertant clones. Virus isolates recovered from infected CNS tissues, despite their temperature-insensitivity, behaved biologically like the orignal stocks of ts mutant virus. These data suggest that temperature-sensitivity is not directly correlated with the unique pathogenesis elicited by infection with ts VSV mutants.

Entities:  

Mesh:

Year:  1977        PMID: 195006     DOI: 10.1099/0022-1317-35-2-237

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Growth and maturation of a vesicular stomatitis virus temperature-sensitive mutant and its central nervous system isolate.

Authors:  J V Hughes; T C Johnson; S G Rabinowitz; M C Dal Canto
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

2.  Persistent infection of a temperature-sensitive G31 vesicular stomatitis virus mutant in neural and nonneural cells: biological and virological characteristics.

Authors:  J Huprikar; S G Rabinowitz; M C DalCanto; M K Rundell
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

3.  Virulence of temperature-sensitive mutants of Sindbis virus in neonatal mice.

Authors:  P N Barrett; G J Atkins
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

4.  Effect of cell-mediated immune factors on the replication of an attenuated temperature-sensitive mutant of vaccinia virus.

Authors:  F Keller; R Drillien; A Kirn
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

5.  Neuroblastoma cell fusion by a temperature-sensitive mutant of vesicular stomatitis virus.

Authors:  J V Hughes; B J Dille; R L Thimmig; T C Johnson; S G Rabinowitz; M C Dal Canto
Journal:  J Virol       Date:  1979-06       Impact factor: 5.103

6.  In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation.

Authors:  J Erik Johnson; John W Coleman; Narender K Kalyan; Priscilla Calderon; Kevin J Wright; Jennifer Obregon; Eleanor Ogin-Wilson; Robert J Natuk; David K Clarke; Stephen A Udem; David Cooper; R Michael Hendry
Journal:  Vaccine       Date:  2009-03-13       Impact factor: 3.641

7.  Murine central nervous system infection by a viral temperature-sensitive mutant: a subacute disease leading to demyelination.

Authors:  M C Dal Canto; S G Rabinowitz
Journal:  Am J Pathol       Date:  1981-03       Impact factor: 4.307

8.  Neuropeptide-induced hypothermia and the course of central nervous system disease mediated by temperature-sensitive mutants of vesicular stomatitis virus.

Authors:  S C Doll; T C Johnson
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.